Koers Optigenex Inc. Other OTC
Aandelen
OPGX
US6838863032
Farmaceutische producten
Omzet 2006 | 301K 280K | Omzet 2007 | 466K 434K | Marktkapitalisatie | 44,73K 41,68K |
---|---|---|---|---|---|
Nettowinst (verlies) 2006 | -7 mln. -6,52 mln. | Nettowinst (verlies) 2007 | -2 mln. -1,86 mln. | EV/omzet 2006 | 20,5 x |
Nettoschuld 2006 | 6 mln. 5,59 mln. | Nettoschuld 2007 | 8,93 mln. 8,32 mln. | EV/omzet 2007 | 19,3 x |
K/w-verhouding 2006 * |
-
| K/w-verhouding 2007 |
-
| Werknemers | - |
Dividendrendement 2006 * |
-
| Dividendrendement 2007 |
-
| Vrij verhandelbaar | 21,27% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel A. Zwiren
CEO | Chief Executive Officer | 67 | 13-05-06 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel A. Zwiren
CEO | Chief Executive Officer | 67 | 13-05-06 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,68% | 699 mld. | |
+25,07% | 571 mld. | |
-4,35% | 364 mld. | |
+17,65% | 326 mld. | |
+3,77% | 286 mld. | |
+14,68% | 236 mld. | |
+4,71% | 198 mld. | |
-12,43% | 194 mld. | |
-3,79% | 154 mld. |